Amgen Inc (NASDAQ:AMGN) over-valued by 8%
| Website | http://www.amgen.com |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $144,431,382,528 |
| Beta | 0.735245 |
| Average Volume | $2,790,800 |
| Last Dividend | 8.32% |
| Price on Apr 28, 2021 | $251.38 |
| Autochartist™ Valuation | $232.19 |
| Conclusion |
8% over-valued |
| Download Report |
